net dbt
ep beat bofa estim
report result morn adjust ep beat estim
consensu respect driven better expect gross margin
upsid better line item upsid expect
stock react posit today organ sale show signific improv
vs estim cag synergi target increas give
cushion takeaway press releas report sale
in-lin estim organ sale beat estim
differ lender divestitur monthli phase pinnacl
organ one month quarter organ sale segment came
better expect groceri snack vs estim
refriger frozen vs estim vs
estim addit press releas indic challeng
brand pinnacl food legaci show improv view key
question call mitig differ consumpt
shipment data result came recent scanner data trend gross margin
forecast driven favor cost synergi off-set
divestitur inflat retail invest realiz increment
cost synergi quarter bring ytd save vs increas target
oper incom beat forecast driven
gross margin leverag sg expens in-lin
expect line item ad upsid jv incom ardent
mill estim driven favor market condit
interest expens estim tax rate
estim quarter
updat guidanc divestitur save
updat outlook reflect expect divestitur lender
busi expect reduc net sale adjust ep
note addit previous announc divestitur dsd snack privat
label peanut butter busi addit increas total annual cost save
target end manag expect reinvest
addit cost save drive long-term sale initi
guidanc includ adjust ep
lender divestitur organ sale growth unchang net
sale growth due
divestitur oper margin unchang
maintain buy rate po base estim
in-lin packag food peer average expect improv visibl
faster averag growth next year
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net incom cont op item
price object base target multipl estim
line packag food peer averag base anticip delay
benefit/accret pinnacl food pf merger may take time gain
investor confid potenti valu creation pf deal view
provid abil grow better averag sale earn
downsid risk price object inabl execut cost-sav initi
strateg action well higher-than-expect declin sale
bryan spillan herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
